Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2012 (2012), Article ID 751694, 9 pages
http://dx.doi.org/10.1155/2012/751694
Review Article

Glucocorticoids and Preterm Hypoxic-Ischemic Brain Injury: The Good and the Bad

Fetal Physiology and Neuroscience Group, Department of Physiology, The University of Auckland, Auckland 1142, New Zealand

Received 27 March 2012; Accepted 13 July 2012

Academic Editor: Janna Morrison

Copyright © 2012 Laura Bennet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Liggins and R. N. Howie, “A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants,” Pediatrics, vol. 50, no. 4, pp. 515–525, 1972. View at Google Scholar · View at Scopus
  2. L. C. Gilstrap, R. Christensen, W. H. Clewell et al., “Effect of corticosteroids for fetal maturation on perinatal outcomes,” Journal of the American Medical Association, vol. 273, no. 5, pp. 413–418, 1995. View at Google Scholar
  3. D. Roberts and S. Dalziel, “Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD004454, 2006. View at Google Scholar · View at Scopus
  4. O. Baud, L. Foix-L'Helias, M. Kaminski et al., “Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants,” New England Journal of Medicine, vol. 341, no. 16, pp. 1190–1196, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Whitelaw and M. Thoresen, “Antenatal steroids and the developing brain,” Archives of Disease in Childhood, vol. 83, no. 2, pp. F154–F157, 2000. View at Google Scholar · View at Scopus
  6. I. Antonow-Schlorke, A. Helgert, and C. Gey et al., “Adverse effects of antenatal glucocorticoids on cerebral myelination in sheep,” Obstetrics & Gynecology, vol. 113, no. 1, pp. 142–151, 2009. View at Google Scholar · View at Scopus
  7. M. Schwab, I. Antonow-Schlorke, B. Kühn et al., “Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep,” Journal of Physiology, vol. 530, no. 3, pp. 497–506, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Antonow-Schlorke, B. Kühn, T. Müller et al., “Antenatal betamethasone treatment reduces synaptophysin immunoreactivity in presynaptic terminals in the fetal sheep brain,” Neuroscience Letters, vol. 297, no. 3, pp. 147–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Antonow-Schlorke, M. Schwab, C. Li, and P. W. Nathanielsz, “Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain,” Journal of Physiology, vol. 547, no. 1, pp. 117–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Dunlop, M. A. Archer, J. A. Quinlivan, L. D. Beazley, and J. P. Newnham, “Repeated prenatal corticosteroids delay myelination in the ovine Central Nervous System,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 6, no. 6, pp. 309–313, 1997. View at Google Scholar · View at Scopus
  11. W. L. Huang, C. G. Harper, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep,” International Journal of Developmental Neuroscience, vol. 19, no. 4, pp. 415–425, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Scheepens, M. van de Waarenbug, D. van den Hove, and C. E. Blanco, “A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis,” Journal of Physiology, vol. 552, no. 1, pp. 163–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Schwab, M. Roedel, M. Akhtar Anwar et al., “Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow,” Journal of Physiology, vol. 528, no. 3, pp. 619–632, 2000. View at Google Scholar · View at Scopus
  14. M. Schwab, K. Schmidt, M. Roedel et al., “Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep,” Journal of Physiology, vol. 531, no. 2, pp. 535–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. W. L. Huang, L. D. Beazley, J. A. Quinlivan, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Effect of corticosteroids on brain growth in fetal sheep,” Obstetrics and Gynecology, vol. 94, no. 2, pp. 213–218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. N. P. French, R. Hagan, S. F. Evans, A. Mullan, and J. P. Newnham, “Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior,” American Journal of Obstetrics and Gynecology, vol. 190, no. 3, pp. 588–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. MacArthur, R. N. Howie, J. A. Dezoete, and J. Elkins, “Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone,” Pediatrics, vol. 68, no. 5, pp. 638–643, 1981. View at Google Scholar · View at Scopus
  18. B. A. MacArthur, R. N. Howie, J. A. Dezoete, and J. Elkins, “School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone,” Pediatrics, vol. 70, no. 1, pp. 99–105, 1982. View at Google Scholar · View at Scopus
  19. H. Smolders-De Haas, J. Neuvel, B. Schmand, P. E. Treffers, J. G. Koppe, and J. Hoeks, “Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up,” Pediatrics, vol. 86, no. 1, pp. 65–70, 1990. View at Google Scholar · View at Scopus
  20. D. J. Murphy, “Effect of antenatal corticosteroids on postmortem brain weight of preterm babies,” Early Human Development, vol. 63, no. 2, pp. 113–122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. W. Y. Tam, V. Chau, D. M. Ferriero et al., “Preterm birth: preterm cerebellar growth impairment after postnatal exposure to glucocorticoids,” Science Translational Medicine, vol. 3, no. 105, p. 105ra105, 2011. View at Publisher · View at Google Scholar
  22. O. Baud and A. Sola, “Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain?” Seminars in Fetal and Neonatal Medicine, vol. 12, no. 4, pp. 273–279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. S. Shinwell and S. Eventov-Friedman, “Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis,” Seminars in Fetal and Neonatal Medicine, vol. 14, no. 3, pp. 164–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Modi, H. Lewis, N. Al-Naqeeb, M. Ajayi-Obe, C. J. Dore, and M. Rutherford, “The effects of repeated antenatal glucocorticoid therapy on the developing brain,” Pediatric Research, vol. 50, no. 5, pp. 581–585, 2001. View at Google Scholar · View at Scopus
  25. A. Ali Khan, A. Rodriguez, M. Kaakinen, A. Pouta, A. L. Hartikainen, and M. R. Jarvelin, “Does in utero exposure to synthetic glucocorticoids influence birthweight, head circumference and birth length? A systematic review of current evidence in humans,” Paediatric and Perinatal Epidemiology, vol. 25, no. 1, pp. 20–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Leao, J. C. Sousa, M. Oliveira, R. Silva, O. F. X. Almeida, and N. Sousa, “Programming effects of antenatal dexamethasone in the developing mesolimbic pathways,” Synapse, vol. 61, no. 1, pp. 40–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Uno, L. Lohmiller, C. Thieme et al., “Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques—I. Hippocampus,” Developmental Brain Research, vol. 53, no. 2, pp. 157–167, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. C. W. Noorlander, G. H. A. Visser, G. M. J. Ramakers, P. G. J. Nikkels, and P. N. E. De Graan, “Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan,” Developmental Neurobiology, vol. 68, no. 2, pp. 237–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. G. Zuloaga, D. L. Carbone, R. Hiroi, D. L. Chong, and R. J. Handa, “Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner,” Neuroscience, vol. 199, pp. 535–547, 2011. View at Publisher · View at Google Scholar
  30. K. K. Noguchi, K. C. Walls, D. F. Wozniak, J. W. Olney, K. A. Roth, and N. B. Farber, “Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death,” Cell Death and Differentiation, vol. 15, no. 10, pp. 1582–1592, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Yu, A. V. Patchev, Y. Wu et al., “Depletion of the neural precursor cell pool by glucocorticoids,” Annals of Neurology, vol. 67, no. 1, pp. 21–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Damsted, A. P. Born, O. B. Paulson, and P. Uldall, “Exogenous glucocorticoids and adverse cerebral effects in children,” European Journal of Paediatric Neurology, vol. 15, no. 6, pp. 465–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. L. Halliday, R. A. Ehrenkranz, and L. W. Doyle, “Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001145, 2009. View at Google Scholar · View at Scopus
  34. Committee on Understanding Premature Birth and Assuring Healthy Outcomes, “Preterm Birth: Causes, Consequences, and Prevention,” R. E. Behrman and A. S. Butler, Eds., Institute of Medicine, The National Academies Press, 2007, http://books.nap.edu//catalog/11622.html#toc. View at Google Scholar
  35. Centers for Disease Control and Prevention (CDC), “Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment—United States, 2003,” Morbidity and Mortality Weekly Report, vol. 53, no. 3, pp. 57–59, 2004. View at Google Scholar
  36. Committee on Understanding Premature Birth and Assuring Healthy Outcomes, “Preterm Birth: Causes, Consequences, and Prevention,” R. E. Behrman and A. S. Butler, Eds., Institute of Medicine of the National Academies, Washington, DC, USA, 2005. View at Google Scholar
  37. D. Wilson-Costello, H. Friedman, N. Minich, A. A. Fanaroff, and M. Hack, “Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s,” Pediatrics, vol. 115, no. 4, pp. 997–1003, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. L. J. Woodward, P. J. Anderson, N. C. Austin, K. Howard, and T. E. Inder, “Neonatal MRI to predict neurodevelopmental outcomes in preterm infants,” New England Journal of Medicine, vol. 355, no. 7, pp. 685–694, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Saigal and L. W. Doyle, “An overview of mortality and sequelae of preterm birth from infancy to adulthood,” The Lancet, vol. 371, no. 9608, pp. 261–269, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. E. G. Hamrick, S. P. Miller, C. Leonard et al., “Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia,” Journal of Pediatrics, vol. 145, no. 5, pp. 593–599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. B. S. Peterson, B. Vohr, L. H. Staib et al., “Regional brain volume abnormalities and long-term cognitive outcome in preterm infants,” Journal of the American Medical Association, vol. 284, no. 15, pp. 1939–1947, 2000. View at Google Scholar · View at Scopus
  42. C. K. Shapiro-Mendoza, K. M. Tomashek, M. Kotelchuck et al., “Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk,” Pediatrics, vol. 121, no. 2, pp. e223–e232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. S. S. Billiards, C. R. Pierson, R. L. Haynes, R. D. Folkerth, and H. C. Kinney, “Is the late preterm infant more vulnerable to gray matter injury than the term infant?” Clinics in Perinatology, vol. 33, no. 4, pp. 915–933, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. I. S. Baron, K. Erickson, M. D. Ahronovich, R. Baker, and F. R. Litman, “Cognitive deficit in preschoolers born late-preterm,” Early Human Development, vol. 87, no. 2, pp. 115–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Woythaler, M. C. McCormick, and V. C. Smith, “Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants,” Pediatrics, vol. 127, no. 3, pp. e622–e629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Low, “Reflections on the occurrence and significance of antepartum fetal asphyxia,” Best Practice and Research, vol. 18, no. 3, pp. 375–382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. D. Barrett, L. Bennet, J. Davidson et al., “Destruction and reconstruction: hypoxia and the developing brain,” Birth Defects Research Part C, vol. 81, no. 3, pp. 163–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Wang, H. Hagberg, C. Nie, C. Zhu, T. Ikeda, and C. Mallard, “Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia,” Journal of Neuropathology and Experimental Neurology, vol. 66, no. 6, pp. 552–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Eklind, C. Mallard, A. L. Leverin et al., “Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury,” European Journal of Neuroscience, vol. 13, no. 6, pp. 1101–1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Larouche, M. Roy, H. Kadhim, A. M. Tsanaclis, D. Fortin, and G. Sébire, “Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy,” Developmental Neuroscience, vol. 27, no. 2–4, pp. 134–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. B. J. Stoll, N. I. Hansen, I. Adams-Chapman et al., “Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection,” Journal of the American Medical Association, vol. 292, no. 19, pp. 2357–2365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Low, H. Killen, and E. J. Derrick, “Antepartum fetal asphyxia in the preterm pregnancy,” American Journal of Obstetrics and Gynecology, vol. 188, no. 2, pp. 461–465, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. B. H. Lee, B. J. Stoll, S. A. McDonald, and R. D. Higgins, “Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone,” Pediatrics, vol. 117, no. 5, pp. 1503–1510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. B. H. Lee, B. J. Stoll, S. A. McDonald, and R. D. Higgins, “Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone,” Pediatrics, vol. 121, no. 2, pp. 289–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. R. Bar-Lev, A. Maayan-Metzger, I. Matok, Z. Heyman, E. Sivan, and J. Kuint, “Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone,” Obstetrics and Gynecology, vol. 104, no. 3, pp. 484–488, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Elimian, D. Garry, R. Figueroa, A. Spitzer, V. Wiencek, and J. G. Quirk, “Antenatal betamethasone compared with dexamethasone (Betacode trial): a randomized controlled trial,” Obstetrics and Gynecology, vol. 110, no. 1, pp. 26–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. P. A. Sandercock and T. Soane, “Corticosteroids for acute ischaemic stroke,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD000064, 2011. View at Google Scholar · View at Scopus
  58. V. L. Smith-Swintosky, L. C. Pettigrew, R. M. Sapolsky et al., “Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 4, pp. 585–598, 1996. View at Google Scholar · View at Scopus
  59. R. M. Sapolsky and W. A. Pulsinelli, “Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications,” Science, vol. 229, no. 4720, pp. 1397–1400, 1985. View at Google Scholar · View at Scopus
  60. T. Koide, T. W. Wieloch, and B. K. Siesjo, “Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis,” Journal of Cerebral Blood Flow and Metabolism, vol. 6, no. 4, pp. 395–404, 1986. View at Google Scholar · View at Scopus
  61. R. M. Sapolsky, “Glucocorticoids, hippocampal damage and the glutamatergic synapse,” Progress in Brain Research, vol. 86, pp. 13–23, 1990. View at Google Scholar · View at Scopus
  62. N. Adachi, J. Chen, K. Liu, S. Tsubota, and T. Arai, “Dexamethasone aggravates ischemia-induced neuronal damage by facilitating the onset of anoxic depolarization and the increase in the intracellular Ca2+ concentration in gerbil hippocampus,” Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 3, pp. 274–280, 1998. View at Google Scholar · View at Scopus
  63. N. Adachi, C. Namba, T. Nagaro, and T. Arai, “Dexamethasone reduces energy utilization in ischemic gerbil brain,” European Journal of Pharmacology, vol. 427, no. 2, pp. 119–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Tsubota, N. Adachi, J. Chen, T. Yorozuya, T. Nagaro, and T. Arai, “Dexamethasone changes brain monoamine metabolism and aggravates ischemic neuronal damage in rats,” Anesthesiology, vol. 90, no. 2, pp. 515–523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Y. Cheng, G. Sun, M. Jin, H. Zhao, G. K. Steinberg, and R. M. Sapolsky, “Blocking glucocorticoid and enhancing estrogenic genomic signaling protects against cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 1, pp. 130–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. H. J. Romijn, M. A. Hofman, and A. Gramsbergen, “At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?” Early Human Development, vol. 26, no. 1, pp. 61–67, 1991. View at Publisher · View at Google Scholar · View at Scopus
  67. J. M. Dean, M. D. Moravec, M. Grafe et al., “Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human,” Developmental Neuroscience, vol. 33, no. 3-4, pp. 251–260, 2011. View at Publisher · View at Google Scholar
  68. J. D. E. Barks, M. Post, and U. I. Tuor, “Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat,” Pediatric Research, vol. 29, no. 6, pp. 558–563, 1991. View at Google Scholar · View at Scopus
  69. Y. Feng, P. G. Rhodes, and A. J. Bhatt, “Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats,” Neuroscience, vol. 179, pp. 223–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. J. Dardzinski, S. L. Smith, J. Towfighi, G. D. Williams, R. C. Vannucci, and M. B. Smith, “Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment,” Pediatric Research, vol. 48, no. 2, pp. 248–255, 2000. View at Google Scholar · View at Scopus
  71. P. D. Chumas, M. R. Del Bigio, J. M. Drake, and U. I. Tuor, “A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia,” Journal of Neurosurgery, vol. 79, no. 3, pp. 414–420, 1993. View at Google Scholar · View at Scopus
  72. T. Ikeda, K. Mishima, N. Aoo et al., “Dexamethasone prevents long-lasting learning impairment following a combination of lipopolysaccharide and hypoxia-ischemia in neonatal rats,” American Journal of Obstetrics and Gynecology, vol. 192, no. 3, pp. 719–726, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Felszeghy, G. Banisadr, W. Rostène, C. Nyakas, and F. Haour, “Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats,” NeuroImmunoModulation, vol. 11, no. 6, pp. 404–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Ekert, N. MacLusky, X. P. Luo et al., “Dexamethasone prevents apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy (HIE) by a reactive oxygen species-independent mechanism,” Brain Research, vol. 747, no. 1, pp. 9–17, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. D. I. Altman, R. S. K. Young, and S. K. Yagel, “Effects of dexamethasone in hypoxic-ischemic brain injury in the neonatal rat,” Biology of the Neonate, vol. 46, no. 3, pp. 149–156, 1984. View at Google Scholar · View at Scopus
  76. K. S. Kauffman, F. J. Seidler, and T. A. Slotkin, “Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms,” Pediatric Research, vol. 35, no. 5, pp. 515–522, 1994. View at Google Scholar · View at Scopus
  77. M. P. Flavin, “Influence of dexamethasone on neurotoxicity caused by oxygen and glucose deprivation in vitro,” Experimental Neurology, vol. 139, no. 1, pp. 34–38, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. S. F. Sorrells, J. R. Caso, C. D. Munhoz, and R. M. Sapolsky, “The stressed CNS: when glucocorticoids aggravate inflammation,” Neuron, vol. 64, no. 1, pp. 33–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Kadekaro, M. Ito, and P. M. Gross, “Local cerebral glucose utilization is increased in acutely adrenalectomized rats,” Neuroendocrinology, vol. 47, no. 4, pp. 329–334, 1988. View at Google Scholar · View at Scopus
  80. H. C. Horner, D. R. Packan, and R. M. Sapolsky, “Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia,” Neuroendocrinology, vol. 52, no. 1, pp. 57–64, 1990. View at Google Scholar · View at Scopus
  81. U. I. Tuor, J. Y. Yager, S. Bascaramurty, and M. R. Del Bigio, “Dexamethasone prevents hypoxia/ischemia-induced reductions in cerebral glucose utilization and high-energy phosphate metabolites in immature brain,” Journal of Neurochemistry, vol. 69, no. 5, pp. 1954–1963, 1997. View at Google Scholar · View at Scopus
  82. R. C. Vannucci, R. M. Brucklacher, and S. J. Vannucci, “Glycolysis and perinatal hypoxic-ischemic brain damage,” Developmental Neuroscience, vol. 27, no. 2–4, pp. 185–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. R. C. Vannucci and S. J. Vannucci, “Glucose metabolism in the developing brain,” Seminars in Perinatology, vol. 24, no. 2, pp. 107–115, 2000. View at Google Scholar · View at Scopus
  84. U. I. Tuor, “Glucocorticoids and the prevention of hypoxic-ischemic brain damage,” Neuroscience and Biobehavioral Reviews, vol. 21, no. 2, pp. 175–179, 1997. View at Publisher · View at Google Scholar · View at Scopus
  85. J. M. Perlman, “Antenatal glucocorticoid, magnesium exposure, and the prevention of brain injury of prematurity,” Seminars in Pediatric Neurology, vol. 5, no. 3, pp. 202–210, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. T. M. Voorhies, D. Rawlinson, and R. C. Vannucci, “Glucose and perinatal hypoxic-ischemic brain damage in the rat,” Neurology, vol. 36, no. 8, pp. 1115–1118, 1986. View at Google Scholar · View at Scopus
  87. R. C. Vannucci, “Cerebral carbohydrate and energy metabolism in perinatal hypoxic-ischemic brain damage,” Brain Pathology, vol. 2, no. 3, pp. 229–234, 1992. View at Google Scholar · View at Scopus
  88. R. C. Vannucci and D. J. Mujsce, “Effect of glucose on perinatal hypoxic-ischemic brain damage,” Biology of the Neonate, vol. 62, no. 4, pp. 215–224, 1992. View at Google Scholar · View at Scopus
  89. M. H. LeBlanc, M. Huang, V. Vig, D. Patel, E. E. Smith, and D. W. Busija, “Glucose affects the severity of hypoxic-ischemic brain injury in newborn pigs,” Stroke, vol. 24, no. 7, pp. 1055–1062, 1993. View at Google Scholar · View at Scopus
  90. R. A. Sheldon, J. C. Partridge, and D. M. Ferriero, “Postischemic hyperglycemia is not protective to the neonatal rat brain,” Pediatric Research, vol. 32, no. 4, pp. 489–493, 1992. View at Google Scholar · View at Scopus
  91. M. H. LeBlanc, M. Huang, D. Patel, E. E. Smith, and M. Devidas, “Glucose given after hypoxic ischemia does not affect brain injury in piglets,” Stroke, vol. 25, no. 7, pp. 1443–1448, 1994. View at Google Scholar · View at Scopus
  92. M. Nedergaard, R. P. Kraig, J. Tanabe, and W. A. Pulsinelli, “Dynamics of interstitial and intracellular pH in evolving brain infarct,” American Journal of Physiology, vol. 260, no. 3, pp. R581–R588, 1991. View at Google Scholar · View at Scopus
  93. A. Schurr, “Bench-to-bedside review: a possible resolution of the glucose paradox of cerebral ischemia,” Critical Care, vol. 6, no. 4, pp. 330–334, 2002. View at Google Scholar · View at Scopus
  94. M. Nedergaard, A. Gjedde, and N. H. Diemer, “Hyperglycaemia protects against neuronal injury around experimental brain infarcts,” Neurological Research, vol. 9, no. 4, pp. 241–244, 1987. View at Google Scholar · View at Scopus
  95. S. Y. Seo, E. Y. Kim, H. Kim, I. Jou, and B. J. Gwag, “Attenuation of neuronal death by NMDA and oxygen-glucose deprivation in cortical neurons maintained in high glucose,” Annals of the New York Academy of Sciences, vol. 893, pp. 396–399, 1999. View at Google Scholar · View at Scopus
  96. G. F. Tian and A. J. Baker, “Glycolysis prevents anoxia-induced synaptic transmission damage in rat hippocampal slices,” Journal of Neurophysiology, vol. 83, no. 4, pp. 1830–1839, 2000. View at Google Scholar · View at Scopus
  97. M. D. Ginsbery, R. Prado, and W. D. Dietrich, “Hyperglycemia reduces the extent of cerebral infarction in rats,” Stroke, vol. 18, no. 3, pp. 570–574, 1987. View at Google Scholar · View at Scopus
  98. M. A. Zasslow, R. G. Pearl, L. M. Shuer, G. K. Steinberg, R. E. Lieberson, and C. P. Larson, “Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats,” Stroke, vol. 20, no. 4, pp. 519–523, 1989. View at Google Scholar · View at Scopus
  99. U. I. Tuor and M. R. Del Bigio, “Protection against hypoxic-ischemic damage with corticosterone and dexamethasone: inhibition of effect by a glucocorticoid antagonist, RU38486,” Brain Research, vol. 743, no. 1-2, pp. 258–262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Mehta, “The glucose paradox of cerebral ischaemia,” Journal of Postgraduate Medicine, vol. 49, no. 4, pp. 299–301, 2003. View at Google Scholar · View at Scopus
  101. A. Ornoy, “Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes,” Pediatric Endocrinology Reviews, vol. 3, no. 2, pp. 104–113, 2005. View at Google Scholar · View at Scopus
  102. A. L. Ogilvy-Stuart and K. Beardsall, “Management of hyperglycaemia in the preterm infant,” Archives of Disease in Childhood, vol. 95, no. 2, pp. F126–F131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. E. J. H. Mulder, R. de Heus, and G. H. A. Visser, “Antenatal corticosteroid therapy: short-term effects on fetal behaviour and haemodynamics,” Seminars in Fetal and Neonatal Medicine, vol. 14, no. 3, pp. 151–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. E. J. H. Mulder, J. B. Derks, and G. H. A. Visser, “Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone,” British Journal of Obstetrics and Gynaecology, vol. 104, no. 11, pp. 1239–1247, 1997. View at Google Scholar · View at Scopus
  105. L. Bennet, S. Kozuma, H. H. G. McGarrigle, and M. A. Hanson, “Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep,” British Journal of Obstetrics and Gynaecology, vol. 106, no. 4, pp. 331–339, 1999. View at Google Scholar · View at Scopus
  106. J. S. Quaedackers, V. Roelfsema, M. Fraser, A. J. Gunn, and L. Bennet, “Cardiovascular and endocrine effects of a single course of maternal dexamethasone treatment in preterm fetal sheep,” British Journal of Obstetrics and Gynaecology, vol. 112, no. 2, pp. 182–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. R. M. Barlow, “The foetal sheep: morphogenesis of the nervous system and histochemical aspects of myelination,” Journal of Comparative Neurology, vol. 135, no. 3, pp. 249–262, 1969. View at Google Scholar · View at Scopus
  108. G. H. McIntosh, K. I. Baghurst, B. J. Potter, and B. S. Hetzel, “Foetal brain development in the sheep,” Neuropathology and Applied Neurobiology, vol. 5, no. 2, pp. 103–114, 1979. View at Google Scholar · View at Scopus
  109. J. McCallum, N. Smith, M. Schwab et al., “Effects of antenatal glucocorticoids on cerebral substrate metabolism in the preterm ovine fetus,” American Journal of Obstetrics and Gynecology, vol. 198, no. 1, pp. e101–e109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. J. O. Davidson, J. S. L. T. Quaedackers, S. A. George, A. J. Gunn, and L. Bennet, “Maternal dexamethasone and EEG hyperactivity in preterm fetal sheep,” Journal of Physiology, vol. 589, no. 15, pp. 3823–3835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. N. S. Mehter, G. B. Sadowska, S. N. Malaeb, and B. S. Stonestreet, “Na+, K+-ATPase activity and subunit isoform protein abundance: effects of antenatal glucocorticoids in the frontal cerebral cortex and renal cortex of ovine fetuses,” Reproductive Sciences, vol. 16, no. 3, pp. 294–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. G. B. Sadowska, S. N. Malaeb, and B. S. Stonestreet, “Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep,” American Journal of Physiology, vol. 298, no. 1, pp. H179–H188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. J. K. Jellyman, D. S. Gardner, C. M. B. Edwards, A. L. Fowden, and D. A. Giussani, “Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep,” Journal of Physiology, vol. 567, no. 2, pp. 673–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. A. J. W. Fletcher, D. S. Gardner, C. M. B. Edwards, A. B. Fowden, and D. A. Giussani, “Cardiovascular and endocrine responses to acute hypoxaemia during and following dexamethasone infusion in the ovine fetus,” Journal of Physiology, vol. 549, no. 1, pp. 271–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. J. K. Jellyman, D. S. Gardner, H. H. G. McGarrigle, A. L. Fowden, and D. A. Giussani, “Pituitary-adrenal responses to acute hypoxemia during and after maternal dexamethasone treatment in sheep,” Pediatric Research, vol. 56, no. 6, pp. 864–872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. A. J. W. Fletcher, M. R. Goodfellow, A. J. Forhead et al., “Low doses of dexamethasone suppress pituitary-adrenal function but augment the glycemic response to acute hypoxemia in fetal sheep during late gestation,” Pediatric Research, vol. 47, no. 5, pp. 684–691, 2000. View at Google Scholar · View at Scopus
  117. A. Saghyan, G. N. LaTorre, R. Keesey et al., “Glutamatergic and morphological alterations associated with early life seizure-induced preconditioning in young rats,” European Journal of Neuroscience, vol. 32, no. 11, pp. 1897–1911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. E. M. Jimenez-Mateos and D. C. Henshall, “Seizure preconditioning and epileptic tolerance: models and mechanisms,” International Journal of Physiology, Pathophysiology and Pharmacology, vol. 1, no. 2, pp. 180–191, 2009. View at Google Scholar · View at Scopus
  119. U. Dirnagl, K. Becker, and A. Meisel, “Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use,” The Lancet Neurology, vol. 8, no. 4, pp. 398–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. U. Dirnagl and A. Meisel, “Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?” Neuropharmacology, vol. 55, no. 3, pp. 334–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. R. D. Sanders, H. J. Manning, N. J. Robertson et al., “Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term,” Anesthesiology, vol. 113, no. 1, pp. 233–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Hagberg, P. Gressens, and C. Mallard, “Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults,” JAnnals of Neurology, vol. 71, no. 4, pp. 444–457, 2012. View at Google Scholar
  123. L. Bennet, L. Booth, and A. J. Gunn, “Potential biomarkers for hypoxic-ischemic encephalopathy,” Seminars in Fetal and Neonatal Medicine, vol. 15, no. 5, pp. 253–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. W. R. Selman, W. D. Lust, S. Pundik, Y. Zhou, and R. A. Ratcheson, “Compromised metabolic recovery following spontaneous spreading depression in the penumbra,” Brain Research, vol. 999, no. 2, pp. 167–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  125. W. W. Hay Jr., S. A. Myers, and J. W. Sparks, “Glucose and lactate oxidation rates in the fetal lamb,” Proceedings of the Society for Experimental Biology and Medicine, vol. 173, no. 4, pp. 553–563, 1983. View at Google Scholar · View at Scopus
  126. R. G. Shulman, F. Hyder, and D. L. Rothman, “Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6417–6422, 2001. View at Publisher · View at Google Scholar · View at Scopus
  127. Z. Wang, W. Luo, P. Li, J. Qiu, and Q. Luo, “Acute hyperglycemia compromises cerebral blood flow following cortical spreading depression in rats monitored by laser speckle imaging,” Journal of Biomedical Optics, vol. 13, no. 6, Article ID 064023, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. C. M. Elitt, G. B. Sadowska, E. G. Stopa, H. Pinar, K. H. Petersson, and B. S. Stonestreet, “Effects of antenatal steroids on ischemic brain injury in near-term ovine fetuses,” Early Human Development, vol. 73, no. 1-2, pp. 1–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. I. M. Abraham, P. Meerlo, and P. G. Luiten, “Concentration dependent actions of glucocorticoids on neuronal viability and survival,” Dose-Response, vol. 4, pp. 38–54, 2006. View at Google Scholar
  130. W. D. Lust, S. Pundik, J. Zechel, Y. Zhou, M. Buczek, and W. R. Selman, “Changing metabolic and energy profiles in fetal, neonatal, and adult rat brain,” Metabolic Brain Disease, vol. 18, no. 3, pp. 195–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  131. A. J. Gunn and L. Bennet, “Hypothermia in the management of hypoxic-ischemic encephalopathy,” NeoReviews, vol. 3, pp. e116–e122, 2002. View at Google Scholar